GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AbbVie Inc (WBO:ABBV) » Definitions » 6-1 Month Momentum %

AbbVie (WBO:ABBV) 6-1 Month Momentum %

: 17.44% (As of Today)
View and export this data going back to 2018. Start your Free Trial

6-1 Month Momentum % is the total return of the stock from 6-month ago to 1-month ago. As of today (2024-04-18), AbbVie's 6-1 Month Momentum % is 17.44%.

The industry rank for AbbVie's 6-1 Month Momentum % or its related term are showing as below:

WBO:ABBV's 6-1 Month Momentum % is ranked better than
75.56% of 1113 companies
in the Drug Manufacturers industry
Industry Median: -2.64 vs WBO:ABBV: 17.44

Competitive Comparison

For the Drug Manufacturers - General subindustry, AbbVie's 6-1 Month Momentum %, along with its competitors' market caps and 6-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AbbVie 6-1 Month Momentum % Distribution

For the Drug Manufacturers industry and Healthcare sector, AbbVie's 6-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where AbbVie's 6-1 Month Momentum % falls into.



AbbVie  (WBO:ABBV) 6-1 Month Momentum % Calculation

6-1 Month Momentum % is calculated as following:

6-1 Month Momentum %=( Price 1-month ago / Price 6-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AbbVie  (WBO:ABBV) 6-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 6-1 Month Momentum % measures the total return to a stock over the past six months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


AbbVie 6-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of AbbVie's 6-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


AbbVie (WBO:ABBV) Business Description

Address
1 North Waukegan Road, North Chicago, IL, USA, 60064-6400
AbbVie is a pharmaceutical firm with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.

AbbVie (WBO:ABBV) Headlines

From GuruFocus

Q3 2022 Abbvie Inc Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q1 2022 Abbvie Inc Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q3 2023 Abbvie Inc Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q4 2021 Abbvie Inc Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q3 2021 Abbvie Inc Earnings Call Transcript

By GuruFocus Research 01-22-2024